Here are five takeaways:
1. In February, Exactech’s total short interest reached 303,600 shares.
2. Exactech’s short interest float is 2.3 percent.
3. On Feb. 26, the shares rallied 0.76 percent, reaching $18.66.
4. The shares have fallen 7.58 percent since July 23, 2015.
5. Exactech’s shares have underperformed the S&P 500 by 0.25 percent.
More articles on devices:
InVivo Therapeutics receives Objective Performance Criterion for study: 5 insights
North America dominates global orthopedic prosthetic devices market: 5 things to know
Integra LifeSciences Holdings short interest decreases: 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
